Clinical Trial Update: Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth. [Phase 4]

View source ↗

Summary

Phase 4 study assessing immunogenicity and safety of Rotarix in Taiwanese infants who received hepatitis B immunoglobulin at birth; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis
• Rotavirus Infection

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 4 | Status: COMPLETED | Results posted: 2012-04-17